163 related articles for article (PubMed ID: 34356051)
1. Retinoic Acid-Induced Gene G(RIG-G) as a Novel Monitoring Biomarker in Leukemia and Its Clinical Applications.
Wang F; Tian J; Pang L; Wu J; Shang A; Sun Z; Li D; Yan J; Quan W
Genes (Basel); 2021 Jul; 12(7):. PubMed ID: 34356051
[TBL] [Abstract][Full Text] [Related]
2. Circulating lnc-LOC as a novel noninvasive biomarker in the treatment surveillance of acute promyelocytic leukaemia.
Wang G; Yan G; Sang K; Yang H; Sun N; Bai Y; Xu F; Zheng X; Chen Z
BMC Cancer; 2022 May; 22(1):481. PubMed ID: 35501730
[TBL] [Abstract][Full Text] [Related]
3. miR-638 in circulating leukaemia cells as a non-invasive biomarker in diagnosis, treatment response and MRD surveillance of acute promyelocytic leukaemia.
Bai Y; Chen C; Guo X; Ding T; Yang X; Yu J; Yang J; Ruan J; Zheng X; Chen Z
Cancer Biomark; 2020; 29(1):125-137. PubMed ID: 32568176
[TBL] [Abstract][Full Text] [Related]
4. RIG-G inhibits the proliferation of NB4 cells and propels ATRA-induced differentiation of APL cells.
Lou YJ; Pan XR; Jia PM; Jin J; Tong JH
Leuk Res; 2016 Jan; 40():83-9. PubMed ID: 26686474
[TBL] [Abstract][Full Text] [Related]
5. [Regulation mechanism for rig-g gene expression induced by all-trans retinoic acid].
Pan XR; Lou YJ; Zhang ZL; Xu GP; Jia PM; Tong JH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Feb; 18(1):31-5. PubMed ID: 20137113
[TBL] [Abstract][Full Text] [Related]
6. Profiling and functional analysis of circular RNAs in acute promyelocytic leukemia and their dynamic regulation during all-trans retinoic acid treatment.
Li S; Ma Y; Tan Y; Ma X; Zhao M; Chen B; Zhang R; Chen Z; Wang K
Cell Death Dis; 2018 May; 9(6):651. PubMed ID: 29844435
[TBL] [Abstract][Full Text] [Related]
7. Changes in microrheology of acute promyelocytic leukemia cells during all-trans retinoic acid (ATRA) differentiation therapy: a mechanism for ATRA-induced hyperleukocytosis?
Dombret H; Geiger S; Daniel MT; Glaisner S; Micléa JM; Castaigne S; Merle-Beral H; Lacombe C; Chomienne C; Degos L
Leukemia; 1995 Sep; 9(9):1473-7. PubMed ID: 7658714
[TBL] [Abstract][Full Text] [Related]
8. Modulation of IL-8, IL-1 beta, and G-CSF secretion by all-trans retinoic acid in acute promyelocytic leukemia.
Dubois C; Schlageter MH; de Gentile A; Balitrand N; Toubert ME; Krawice I; Fenaux P; Castaigne S; Najean Y; Degos L
Leukemia; 1994 Oct; 8(10):1750-7. PubMed ID: 7523800
[TBL] [Abstract][Full Text] [Related]
9. All-trans retinoic acid potentiates megakaryocyte colony formation: in vitro and in vivo effects after administration to acute promyelocytic leukemia patients.
Visani G; Zauli G; Tosi P; Ottaviani E; Gibellini D; Manfroi S; Celeghini C; Pagliarini C; Bassini A; Tura S
Leukemia; 1994 Dec; 8(12):2183-7. PubMed ID: 7528859
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-8 is not a predictive biomarker for the development of the acute promyelocytic leukemia differentiation syndrome.
Yamamoto de Almeida L; Pereira-Martins DA; Lima ASG; Baggio MS; de Araujo Koury LC; Lange AP; Bassi SC; Scheucher PS; Rego EM
BMC Cancer; 2020 Aug; 20(1):821. PubMed ID: 32859169
[TBL] [Abstract][Full Text] [Related]
11. Potentiated maturation with a high proliferating activity of acute promyelocytic leukemia induced in vitro by granulocyte or granulocyte/macrophage colony-stimulating factors in combination with all-trans retinoic acid.
Imaizumi M; Sato A; Koizumi Y; Inoue S; Suzuki H; Suwabe N; Yoshinari M; Ichinohasama R; Endo K; Sawai T
Leukemia; 1994 Aug; 8(8):1301-8. PubMed ID: 7520101
[TBL] [Abstract][Full Text] [Related]
12. Missense mutations in the PML/RARalpha ligand binding domain in ATRA-resistant As(2)O(3) sensitive relapsed acute promyelocytic leukemia.
Marasca R; Zucchini P; Galimberti S; Leonardi G; Vaccari P; Donelli A; Luppi M; Petrini M; Torelli G
Haematologica; 1999 Nov; 84(11):963-8. PubMed ID: 10553155
[TBL] [Abstract][Full Text] [Related]
13. Peripheral blood and bone marrow changes after treatment with ATRA and G-CSF in AML, APL and blast crisis following Vaquez's disease.
Notario A; Rolandi ML; Mazzucchelli I
Haematologica; 1996; 81(3):261-4. PubMed ID: 8767533
[TBL] [Abstract][Full Text] [Related]
14. Molecular monitoring of the myl/retinoic acid receptor-alpha fusion gene in acute promyelocytic leukemia by polymerase chain reaction.
Biondi A; Rambaldi A; Pandolfi PP; Rossi V; Giudici G; Alcalay M; Lo Coco F; Diverio D; Pogliani EM; Lanzi EM
Blood; 1992 Jul; 80(2):492-7. PubMed ID: 1320955
[TBL] [Abstract][Full Text] [Related]
15. Neutrophil secondary-granule deficiency as a hallmark of all-trans retinoic acid-induced differentiation of acute promyelocytic leukemia cells.
Miyauchi J; Ohyashiki K; Inatomi Y; Toyama K
Blood; 1997 Jul; 90(2):803-13. PubMed ID: 9226181
[TBL] [Abstract][Full Text] [Related]
16. All-trans retinoic acid therapy in relapsed/refractory or newly diagnosed acute promyelocytic leukemia (APL) in Japan.
Ohno R; Ohnishi K; Takeshita A; Tanimoto M; Murakami H; Kanamaru A; Asou N; Kobayashi T; Kuriyama K; Ohmoto E
Leukemia; 1994; 8 Suppl 3():S64-9. PubMed ID: 7808028
[TBL] [Abstract][Full Text] [Related]
17. Treatment of newly diagnosed and relapsed acute promyelocytic leukemia with intravenous liposomal all-trans retinoic acid.
Douer D; Estey E; Santillana S; Bennett JM; Lopez-Bernstein G; Boehm K; Williams T
Blood; 2001 Jan; 97(1):73-80. PubMed ID: 11133744
[TBL] [Abstract][Full Text] [Related]
18. [Effects of all-trans retinoic acid and arsenic trioxide on tissue factor expression of acute promyelocytic leukemia cells].
Guo W; Wang H; Zhao W
Zhonghua Yi Xue Za Zhi; 2000 May; 80(5):327-31. PubMed ID: 11798779
[TBL] [Abstract][Full Text] [Related]
19. [Detection of PML/RARalpha gene transcripts in 46 newly diagnosed acute promyelocytic leukemia patients by real-time quantitative reverse-transcription polymerase chain reaction].
Zhu HH; Liu YR; Qin YZ; Li JL; Chang Y; Wang YZ; Shan FX; Jiang B; Lu DP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Feb; 15(1):1-5. PubMed ID: 17490509
[TBL] [Abstract][Full Text] [Related]
20. Genome‑wide profiling of lncRNA expression patterns in patients with acute promyelocytic leukemia with differentiation therapy.
Yu J; Guo XL; Bai YY; Yang JJ; Zheng XQ; Ruan JC; Chen ZG
Oncol Rep; 2018 Sep; 40(3):1601-1613. PubMed ID: 29956795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
